These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29062135)

  • 1. Increased HSP27 correlates with malignant biological behavior of non-small cell lung cancer and predicts patient's survival.
    Sheng B; Qi C; Liu B; Lin Y; Fu T; Zeng Q
    Sci Rep; 2017 Oct; 7(1):13807. PubMed ID: 29062135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
    Wang D; Hao T; Pan Y; Qian X; Zhou D
    Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasohibin-1 expression detected by immunohistochemistry correlates with prognosis in non-small cell lung cancer.
    Zhang T; Yu TT; Zhang DM; Hou XM; Liu XJ; Zhao D; Shan L
    Med Oncol; 2014 May; 31(5):963. PubMed ID: 24748406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of MAC30 is associated with poor clinical outcome in human non-small-cell lung cancer.
    Han KY; Gu X; Wang HR; Liu D; Lv FZ; Li JN
    Tumour Biol; 2013 Apr; 34(2):821-5. PubMed ID: 23229099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients.
    Wei LX; Zhou RS; Xu HF; Wang JY; Yuan MH
    Tumour Biol; 2013 Apr; 34(2):941-6. PubMed ID: 23264086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginkgo biloba extract decreases non-small cell lung cancer cell migration by downregulating metastasis-associated factor heat-shock protein 27.
    Tsai JR; Liu PL; Chen YH; Chou SH; Yang MC; Cheng YJ; Hwang JJ; Yin WH; Chong IW
    PLoS One; 2014; 9(3):e91331. PubMed ID: 24618684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of RUNX2 expression in patients with nonsmall cell lung cancer: a 5-year follow-up study.
    Li H; Zhou RJ; Zhang GQ; Xu JP
    Tumour Biol; 2013 Jun; 34(3):1807-12. PubMed ID: 23471668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p114RhoGEF predicts lymph node metastasis and poor survival of squamous-cell lung carcinoma patients.
    Song C; Gao Y; Tian Y; Han X; Chen Y; Tian DL
    Tumour Biol; 2013 Jun; 34(3):1925-33. PubMed ID: 23512329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and significance of hypoxia inducible factor-1α and lysyl oxidase in non-small cell lung cancer.
    Ping W; Jiang WY; Chen WS; Sun W; Fu XN
    Asian Pac J Cancer Prev; 2013; 14(6):3613-8. PubMed ID: 23886154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GOLPH3 high expression predicts poor prognosis in patients with resected non-small cell lung cancer: an immunohistochemical analysis.
    Zhang Y; Ma M; Han B
    Tumour Biol; 2014 Nov; 35(11):10833-9. PubMed ID: 25081375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAM17 is overexpressed in non-small cell lung cancer and its expression correlates with poor patient survival.
    Ni SS; Zhang J; Zhao WL; Dong XC; Wang JL
    Tumour Biol; 2013 Jun; 34(3):1813-8. PubMed ID: 23475633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
    Zhang Z; Guo Y
    Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HSPA2 is expressed in human tumors and correlates with clinical features in non-small cell lung carcinoma patients.
    Scieglinska D; Gogler-Piglowska A; Butkiewicz D; Chekan M; Malusecka E; Harasim J; Habryka A; Krawczyk Z
    Anticancer Res; 2014 Jun; 34(6):2833-40. PubMed ID: 24922646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of sonic hedgehog signaling pathway components on non-small-cell lung cancer progression and clinical outcome.
    Hwang J; Kang MH; Yoo YA; Quan YH; Kim HK; Oh SC; Choi YH
    World J Surg Oncol; 2014 Aug; 12():268. PubMed ID: 25141859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTOR and PTEN expression in non-small cell lung cancer: analysis by real-time fluorescence quantitative polymerase chain reaction and immunohistochemistry.
    Wang L; Yue W; Zhang L; Zhao X; Wang Y; Xu S
    Surg Today; 2012 May; 42(5):419-25. PubMed ID: 22127531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of 14-3-3γ overexpression in advanced non-small cell lung cancer.
    Raungrut P; Wongkotsila A; Lirdprapamongkol K; Svasti J; Geater SL; Phukaoloun M; Suwiwat S; Thongsuksai P
    Asian Pac J Cancer Prev; 2014; 15(8):3513-8. PubMed ID: 24870749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
    Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
    J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional promoter -1271G>C variant of HSPB1 predicts lung cancer risk and survival.
    Guo H; Bai Y; Xu P; Hu Z; Liu L; Wang F; Jin G; Wang F; Deng Q; Tu Y; Feng M; Lu D; Shen H; Wu T
    J Clin Oncol; 2010 Apr; 28(11):1928-35. PubMed ID: 20231684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular and clinical verification of therapeutic resistance via the p38 MAPK-Hsp27 axis in lung cancer.
    Liu CL; Chen SF; Wu MZ; Jao SW; Lin YS; Yang CY; Lee TY; Wen LW; Lan GL; Nieh S
    Oncotarget; 2016 Mar; 7(12):14279-90. PubMed ID: 26872057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The overexpression of 14-3-3ζ and Hsp27 promotes non–small cell lung cancer progression.
    Zhao GY; Ding JY; Lu CL; Lin ZW; Guo J
    Cancer; 2014 Mar; 120(5):652-63. PubMed ID: 24804299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.